--- title: "Levima: The company has completed the development of PEEK-related technology and product pilot testing, and is advancing industrialization" type: "News" locale: "en" url: "https://longbridge.com/en/news/256691772.md" description: "Levima responded on the interactive platform on September 10th, stating that PEEK-related materials are one of the key products the company focuses on and researches. The company has currently completed the technical development and pilot testing of PEEK-related products and is advancing towards industrialization" datetime: "2025-09-10T08:18:38.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/256691772.md) - [en](https://longbridge.com/en/news/256691772.md) - [zh-HK](https://longbridge.com/zh-HK/news/256691772.md) --- # Levima: The company has completed the development of PEEK-related technology and product pilot testing, and is advancing industrialization On September 10th, Levima responded on the interactive platform stating that PEEK-related materials are one of the key products the company focuses on and researches. The company has currently completed the technical development and pilot testing of PEEK-related products and is advancing towards industrialization ### Related Stocks - [003022.CN](https://longbridge.com/en/quote/003022.CN.md) ## Related News & Research - [Dahlonega Now a ‘Gig-Ready’ Community from Kinetic’s Fiber-Optic Network Expansion](https://longbridge.com/en/news/287079090.md) - [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md) - [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md) - [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md) - [4basebio signs clinical supply agreement for Phase II immunotherapy trial opDNA material](https://longbridge.com/en/news/287052696.md)